COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes

Phase 4

Completed

Conditions: Diabetic Ketoacidosis
Type 1 Diabetes Mellitus

Interventions: Drug: Glargine
Device: Continuous Glucose Monitor (Abbott FreeStyle Libre Pro)

First Posted Date: 2017-04-11

Last Posted Date: 2022-05-10

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 61

Registration Number: NCT03107208

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia

Phase 1

Completed

Conditions: Post Gastrointestinal Tract Surgery Hypoglycaemia
Hyperinsulinemic Hypoglycemia

Interventions: Drug: Pasireotide

First Posted Date: 2017-04-06

Last Posted Date: 2021-09-29

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 1

Registration Number: NCT03103009

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion

Phase 2

Completed

Conditions: Urinary Tract Infections
Catheter Infection
Catheter-Related Infections

Interventions: Procedure: Standard of care catheter insertion
Drug: Catheter insertion with Povidone Iodine

First Posted Date: 2017-04-05

Last Posted Date: 2020-03-10

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 99

Registration Number: NCT03101371

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders

Not Applicable

Active, not recruiting

Conditions: Hematologic Disorders

Interventions: Device: Miltenyi CliniMACS® CD34 Reagent System

First Posted Date: 2017-03-28

Last Posted Date: 2025-01-13

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 150

Registration Number: NCT03093844

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome

Phase 4

Completed

Conditions: Anticholinergics Toxicity

Interventions: Drug: Physostigmine
Drug: Lorazepam

First Posted Date: 2017-03-27

Last Posted Date: 2021-08-23

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 19

Registration Number: NCT03090620

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora, Colorado, United States

Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics

Completed

Conditions: Contraception

Interventions: Procedure: Blood draw

First Posted Date: 2017-03-27

Last Posted Date: 2022-08-16

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 900

Registration Number: NCT03092037

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Dietary Supplement: Grape Seed Extract

First Posted Date: 2017-03-23

Last Posted Date: 2025-03-25

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 41

Registration Number: NCT03087903

Locations: 🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States
🇺🇸
Poudre Valley Hospital, Fort Collins, Colorado, United States

Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer, Nonsmall Cell

Interventions: Drug: Crizotinib

First Posted Date: 2017-03-23

Last Posted Date: 2022-02-11

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 3

Registration Number: NCT03088930

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department

Phase 4

Completed

Conditions: Conscious Sedation
Simple Lacerations Less Than 4 cm
Lumbar Punctures
Minor Incision Drainage of Abscesses Not Requiring Extensive Debridement

Interventions: Drug: Midazolam
Drug: Nitrous Oxide

First Posted Date: 2017-03-21

Last Posted Date: 2022-05-10

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 63

Registration Number: NCT03085563

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease

Completed

Conditions: Healthy Controls
Mild Cognitive Impairment

First Posted Date: 2017-03-16

Last Posted Date: 2021-08-09

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 41

Registration Number: NCT03081546

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy